Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery

NCT07027670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Surgical Procedures
Coronary Artery Bypass
Aortic Valve Disease
Mitral Valve Disease

Interventions

DRUG: 5-Aminolevulinic Acid hydrochloride (5-ALA)
OTHER: Placebo
DRUG: Sodium ferrous citrate (SFC)

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]